Genetek Biopharma

Genetek Biopharma is a private, commercial-stage diagnostics company focused on the genetic testing market. Its core business involves the development and sale of proprietary PCR-based kits for applications in clinical diagnostics (e.g., aneuploidy, male infertility), forensic human identification, and animal profiling, particularly for horses. The company operates a B2B model, selling kits and reagents directly to laboratories and research institutions while seeking academic and industrial collaborations for R&D and product validation. With an established product portfolio and direct sales, Genetek appears to be in a revenue-generating phase, targeting niche segments within the broader genetic analysis industry.

PCR and Short Tandem Repeat (STR) marker-based assay development for genetic analysis. The company designs and optimizes reagents and workflows into proprietary in-vitro diagnostic (IVD) kits for clinical, forensic, and animal genetics applications.

Genetek operates in a crowded molecular diagnostics market dominated by global giants like Thermo Fisher Scientific, Qiagen, and Agilent. It competes by focusing on specific application niches (e.g., equine STR profiling) and providing strong customer support, rather than competing on scale. Its competition also includes other specialized kit manufacturers in forensic and veterinary genetics.